Published in Lab Law Weekly, September 7th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Genzyme Corporation.
Report 1: Genzyme Corporation (NASDAQ:GENZ) announced findings from the Study of the Treatment of Articular Repair (STAR) which investigated the safety and effectiveness of Carticel(R) (autologous cultured chondrocytes) in patients who had an inadequate response to a previous knee cartilage repair procedure. This landmark study demonstrated that autologous chondrocyte implantation provided sustained and clinically meaningful improvements in knee function and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.